(+)-alpha-tocopherol multiple interactions ISO RGD:619568 6480464 alpha-Tocopherol inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA] CTD PMID:27257344 (-)-anisomycin multiple interactions ISO RGD:619568 6480464 wogonin inhibits the reaction [Anisomycin results in increased phosphorylation of CAV1 protein] CTD PMID:23246481 (-)-anisomycin increases phosphorylation ISO RGD:619568 6480464 Anisomycin results in increased phosphorylation of CAV1 protein CTD PMID:23246481 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane increases expression ISO RGD:619568 6480464 2, 2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CAV1 protein CTD PMID:19706615 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane multiple interactions ISO RGD:619568 6480464 2 more ... CTD PMID:19706615 13-HPODE increases expression ISO RGD:619568 6480464 13-hydroperoxy-9, 11-octadecadienoic acid results in increased expression of CAV1 mRNA CTD PMID:27257344 17beta-estradiol multiple interactions ISO RGD:619568 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CAV1 mRNA CTD PMID:19619570 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CAV1 mRNA CTD PMID:27174447 17beta-estradiol increases phosphorylation ISO RGD:619568 6480464 Estradiol results in increased phosphorylation of CAV1 protein CTD PMID:18296501 17beta-estradiol decreases expression ISO RGD:619568 6480464 Estradiol results in decreased expression of CAV1 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:619568 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CAV1 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1553438 6480464 Tetrachlorodibenzodioxin results in increased expression of CAV1 mRNA CTD PMID:28238261 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1553438 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CAV1 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:619568 6480464 Tetrachlorodibenzodioxin results in decreased expression of CAV1 mRNA CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CAV mRNA CTD PMID:15358164 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CAV mRNA CTD PMID:15358164 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CAV1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:619568 6480464 Tetrachlorodibenzodioxin affects the expression of CAV1 mRNA CTD PMID:22298810 2-ethoxyethanol increases expression EXP 6480464 2-ethoxyethanol results in increased expression of CAV mRNA CTD PMID:19643169 2-methoxyethanol affects expression EXP 6480464 methyl cellosolve affects the expression of CAV mRNA CTD PMID:19643169 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1553438 6480464 CAV1 affects the reaction [3 more ... CTD PMID:19265715 more ... 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:619568 6480464 3 more ... CTD PMID:24709675 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1553438 6480464 3 more ... CTD PMID:18786521 , PMID:20406653 3,3',4,4'-tetrachlorobiphenyl increases expression ISO RGD:1553438 6480464 3 more ... CTD PMID:18786521 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1553438 6480464 tetrabromobisphenol A results in decreased expression of CAV1 mRNA CTD PMID:25172293 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1553438 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CAV1 mRNA CTD PMID:16054899 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CAV1 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO RGD:1553438 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CAV1 mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine increases expression ISO RGD:619568 6480464 Decitabine results in increased expression of CAV1 mRNA CTD PMID:16367923 5-aza-2'-deoxycytidine multiple interactions ISO RGD:619568 6480464 [Decitabine co-treated with Depsipeptides] results in decreased expression of CAV1 mRNA CTD PMID:17064661 5-fluorouracil affects response to substance ISO RGD:619568 6480464 CAV1 protein affects the susceptibility to Fluorouracil CTD PMID:15352031 5-fluorouracil increases expression ISO RGD:619568 6480464 Fluorouracil results in increased expression of CAV1 mRNA CTD PMID:24737281 5-fluorouracil decreases expression ISO RGD:619568 6480464 Fluorouracil results in decreased expression of CAV1 protein CTD PMID:15352031 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CAV1 mRNA CTD PMID:24780913 acetylcholine multiple interactions ISO RGD:1553438 6480464 Sodium, Dietary affects the reaction [CAV1 protein affects the susceptibility to Acetylcholine] CTD PMID:18178722 acetylsalicylic acid decreases expression EXP 6480464 Aspirin results in decreased expression of CAV1 mRNA CTD PMID:12800193 actinomycin D multiple interactions ISO RGD:619568 6480464 Dactinomycin inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA] CTD PMID:15314095 aflatoxin B1 increases expression ISO RGD:619568 6480464 Aflatoxin B1 results in increased expression of CAV1 mRNA CTD PMID:27153756 aldehydo-D-glucose decreases expression ISO RGD:619568 6480464 Glucose results in decreased expression of CAV1 mRNA, Glucose results in decreased expression of CAV1 protein CTD PMID:19816600 aldehydo-D-glucose multiple interactions ISO RGD:619568 6480464 EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA], Simvastatin inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA] CTD PMID:19816600 all-trans-retinoic acid decreases expression ISO RGD:619568 6480464 Tretinoin results in decreased expression of CAV1 mRNA CTD PMID:21934132 aminoguanidine decreases expression ISO RGD:619568 6480464 pimagedine results in decreased expression of CAV1 protein CTD PMID:19706615 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CAV1 mRNA CTD PMID:16483693 ammonium chloride decreases expression EXP 6480464 Ammonium Chloride results in decreased expression of CAV1 protein CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of CAV1 mRNA CTD PMID:30779732 amphibole asbestos increases expression EXP 6480464 Asbestos, Amphibole results in increased expression of CAV1 mRNA CTD PMID:22352330 antirheumatic drug increases expression ISO RGD:619568 6480464 Antirheumatic Agents results in increased expression of CAV1 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:1553438 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CAV1 mRNA CTD PMID:23650126 arsenite(3-) multiple interactions ISO RGD:619568 6480464 CAV1 protein inhibits the reaction [arsenite results in increased phosphorylation of MAPK1 protein], CAV1 protein inhibits the reaction [arsenite results in increased phosphorylation of MAPK3 protein] CTD PMID:12640124 arsenite(3-) multiple interactions ISO RGD:1553438 6480464 tyrphostin 25 inhibits the reaction [arsenite results in increased phosphorylation of CAV1 protein] CTD PMID:14511371 arsenite(3-) increases phosphorylation ISO RGD:1553438 6480464 arsenite results in increased phosphorylation of CAV1 protein CTD PMID:14511371 arsenous acid decreases expression ISO RGD:619568 6480464 Arsenic Trioxide results in decreased expression of CAV1 mRNA, Arsenic Trioxide results in decreased expression of CAV1 protein CTD PMID:15725085 more ... arsenous acid increases expression ISO RGD:619568 6480464 Arsenic Trioxide results in increased expression of CAV1 mRNA, Arsenic Trioxide results in increased expression of CAV1 protein CTD PMID:17512576 , PMID:22521957 atrazine increases expression ISO RGD:619568 6480464 Atrazine results in increased expression of CAV1 mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO RGD:619568 6480464 Benzo(a)pyrene results in increased expression of CAV1 protein CTD PMID:26657896 benzo[a]pyrene multiple interactions ISO RGD:1553438 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO RGD:1553438 6480464 Benzo(a)pyrene results in increased expression of CAV1 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:1553438 6480464 Benzo(a)pyrene results in decreased expression of CAV1 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:619568 6480464 Benzo(a)pyrene results in decreased expression of CAV1 mRNA CTD PMID:20106945 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:619568 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene multiple interactions ISO RGD:1553438 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA CTD PMID:27858113 beta-carotene decreases expression ISO RGD:619568 6480464 beta Carotene results in decreased expression of CAV1 protein CTD PMID:26733226 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CAV mRNA CTD PMID:18164116 bis(2-ethylhexyl) phthalate increases expression ISO RGD:619568 6480464 Diethylhexyl Phthalate results in increased expression of CAV1 mRNA CTD PMID:31163220 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CAV1 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1553438 6480464 bisphenol A results in increased expression of CAV1 mRNA CTD PMID:30951980 bisphenol A multiple interactions EXP 6480464 bisphenol A inhibits the reaction [SIRT1 protein binds to CAV1 protein], bisphenol A promotes the reaction [ESR2 protein binds to CAV1 protein] CTD PMID:28067316 bisphenol A decreases acetylation EXP 6480464 bisphenol A results in decreased acetylation of CAV1 protein CTD PMID:28067316 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CAV1 mRNA, bisphenol A results in decreased expression of CAV1 protein CTD PMID:27174447 Bisphenol A diglycidyl ether multiple interactions ISO RGD:619568 6480464 2, 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone results in increased expression of CAV1 protein] CTD PMID:16806087 bisphenol F increases expression ISO RGD:1553438 6480464 bisphenol F results in increased expression of CAV1 mRNA CTD PMID:30951980 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of CAV1 protein CTD PMID:25933445 butan-1-ol multiple interactions ISO RGD:619568 6480464 [[Gasoline co-treated with 1-Butanol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CAV1 mRNA CTD PMID:29432896 butyric acid decreases expression EXP 6480464 Butyric Acid results in decreased expression of CAV1 mRNA CTD PMID:12800193 cadmium atom multiple interactions ISO RGD:1553438 6480464 Cadmium promotes the reaction [HMOX1 protein binds to CAV1 protein] CTD PMID:14658758 cadmium dichloride increases expression ISO RGD:619568 6480464 Cadmium Chloride results in increased expression of CAV1 mRNA CTD PMID:26472689 cadmium nitrate decreases expression ISO RGD:619568 6480464 cadmium nitrate results in decreased expression of CAV1 protein CTD PMID:19061949 caffeine increases expression ISO RGD:619568 6480464 Caffeine results in increased expression of CAV1 protein CTD PMID:31195006 calcitriol multiple interactions ISO RGD:619568 6480464 Calcitriol results in increased localization of [VDR protein co-treated with CAV1 protein] CTD PMID:20371703 calcium atom affects transport ISO RGD:1553438 6480464 CAV1 protein affects the transport of Calcium CTD PMID:16428350 calcium(0) affects transport ISO RGD:1553438 6480464 CAV1 protein affects the transport of Calcium CTD PMID:16428350 camptothecin decreases methylation ISO RGD:619568 6480464 Camptothecin results in decreased methylation of CAV1 gene CTD PMID:30720231 carbamazepine affects expression ISO RGD:619568 6480464 Carbamazepine affects the expression of CAV1 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1553438 6480464 Nanotubes, Carbon analog results in decreased expression of CAV1 mRNA CTD PMID:21624382 , PMID:25554681 carboxy-PTIO decreases expression ISO RGD:619568 6480464 1 more ... CTD PMID:19706615 celecoxib increases expression ISO RGD:619568 6480464 Celecoxib results in increased expression of CAV1 protein CTD PMID:18848576 chloropicrin affects expression ISO RGD:619568 6480464 chloropicrin affects the expression of CAV1 mRNA CTD PMID:26352163 chloropicrin decreases expression ISO RGD:619568 6480464 chloropicrin results in decreased expression of CAV1 mRNA CTD PMID:28476498 cholesterol increases transport ISO RGD:619568 6480464 CAV1 protein results in increased transport of Cholesterol CTD PMID:12640124 cholesterol multiple interactions ISO RGD:1553438 6480464 CAV1 protein affects the reaction [Cholesterol affects the localization of APOE protein] CTD PMID:21169230 cholesterol multiple interactions EXP 6480464 Cholesterol promotes the reaction [APOE protein binds to CAV1 protein] CTD PMID:21169230 chromium atom multiple interactions EXP 6480464 [Niacin co-treated with Chromium] inhibits the reaction [CAV1 protein binds to NOS3 protein], [Niacin co-treated with Chromium] results in decreased expression of CAV1 protein CTD PMID:19027847 chrysene decreases expression ISO RGD:1553438 6480464 chrysene results in decreased expression of CAV1 mRNA CTD PMID:26377693 chrysene multiple interactions ISO RGD:1553438 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA CTD PMID:27858113 ciprofloxacin increases expression ISO RGD:619568 6480464 Ciprofloxacin results in increased expression of CAV1 protein CTD PMID:26947806 cisplatin affects response to substance ISO RGD:619568 6480464 CAV1 protein affects the susceptibility to Cisplatin CTD PMID:16217747 cisplatin increases expression ISO RGD:619568 6480464 Cisplatin results in increased expression of CAV1 mRNA CTD PMID:27392435 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of CAV1 mRNA CTD PMID:22023808 cisplatin affects expression ISO RGD:1553438 6480464 Cisplatin affects the expression of CAV1 mRNA CTD PMID:21151649 clofibrate affects expression ISO RGD:619568 6480464 Clofibrate affects the expression of CAV1 protein CTD PMID:17961437 cobalt dichloride decreases expression ISO RGD:619568 6480464 cobaltous chloride results in decreased expression of CAV1 mRNA CTD PMID:19320972 coumestrol multiple interactions ISO RGD:619568 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CAV1 mRNA CTD PMID:19167446 coumestrol increases expression ISO RGD:619568 6480464 Coumestrol results in increased expression of CAV1 mRNA CTD PMID:19167446 cumene decreases expression ISO RGD:1553438 6480464 cumene results in decreased expression of CAV1 mRNA CTD PMID:18648096 cycloheximide multiple interactions ISO RGD:619568 6480464 Cycloheximide inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA] CTD PMID:15314095 cyclosporin A decreases expression ISO RGD:619568 6480464 Cyclosporine results in decreased expression of CAV1 mRNA CTD PMID:20106945 , PMID:27989131 cylindrospermopsin increases expression ISO RGD:619568 6480464 cylindrospermopsin results in increased expression of CAV1 mRNA CTD PMID:24921660 cyproconazole decreases expression ISO RGD:619568 6480464 cyproconazole results in decreased expression of CAV1 mRNA CTD PMID:26238599 D-glucose multiple interactions ISO RGD:619568 6480464 EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA], Simvastatin inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA] CTD PMID:19816600 D-glucose decreases expression ISO RGD:619568 6480464 Glucose results in decreased expression of CAV1 mRNA, Glucose results in decreased expression of CAV1 protein CTD PMID:19816600 depsipeptide multiple interactions ISO RGD:619568 6480464 [decitabine co-treated with Depsipeptides] results in decreased expression of CAV1 mRNA CTD PMID:17064661 desferrioxamine B increases expression ISO RGD:619568 6480464 Deferoxamine results in increased expression of CAV1 protein CTD PMID:16927372 dexamethasone multiple interactions ISO RGD:1553438 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CAV1 mRNA more ... CTD PMID:14984747 , PMID:16054899 dexamethasone multiple interactions ISO RGD:619568 6480464 [Dexamethasone results in increased expression of CAV1 protein] which results in decreased susceptibility to VEGFA protein CTD PMID:23426970 dexamethasone increases expression ISO RGD:619568 6480464 Dexamethasone results in increased expression of CAV1 mRNA, Dexamethasone results in increased expression of CAV1 protein CTD PMID:23426970 , PMID:25047013 diallyl disulfide multiple interactions ISO RGD:619568 6480464 diallyl disulfide promotes the reaction [NOS3 protein binds to CAV1 protein] CTD PMID:20229525 diallyl trisulfide multiple interactions ISO RGD:619568 6480464 diallyl trisulfide promotes the reaction [NOS3 protein binds to CAV1 protein] CTD PMID:20229525 diarsenic trioxide increases expression ISO RGD:619568 6480464 Arsenic Trioxide results in increased expression of CAV1 mRNA, Arsenic Trioxide results in increased expression of CAV1 protein CTD PMID:17512576 , PMID:22521957 diarsenic trioxide decreases expression ISO RGD:619568 6480464 Arsenic Trioxide results in decreased expression of CAV1 mRNA, Arsenic Trioxide results in decreased expression of CAV1 protein CTD PMID:15725085 more ... dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CAV1 mRNA CTD PMID:21266533 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CAV1 mRNA CTD PMID:21658437 dioxygen multiple interactions ISO RGD:1553438 6480464 [CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency] which results in increased expression of NOX2 mRNA more ... CTD PMID:24835767 dioxygen increases expression ISO RGD:619568 6480464 Oxygen deficiency results in increased expression of CAV1 mRNA, Oxygen deficiency results in increased expression of CAV1 protein CTD PMID:18717816 dioxygen multiple interactions ISO RGD:619568 6480464 [Oxygen deficiency co-treated with 1-hydroxy-2-oxo-3 more ... CTD PMID:18717816 dioxygen multiple interactions EXP 6480464 [Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV1 mRNA more ... CTD PMID:16698853 , PMID:24835767 dioxygen increases response to substance ISO RGD:1553438 6480464 CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency CTD PMID:24835767 diuron decreases expression EXP 6480464 Diuron results in decreased expression of CAV1 mRNA CTD PMID:21551480 , PMID:25152437 dorsomorphin multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:619568 6480464 CAV1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin increases expression ISO RGD:1553438 6480464 Doxorubicin results in increased expression of CAV1 mRNA CTD PMID:22008532 equol multiple interactions ISO RGD:619568 6480464 Equol inhibits the reaction [NOS3 protein binds to CAV1 protein] CTD PMID:16840783 ethanol increases expression ISO RGD:619568 6480464 Ethanol results in increased expression of CAV1 mRNA CTD PMID:15963989 ethanol multiple interactions ISO RGD:1553438 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CAV1 mRNA CTD PMID:30517762 ethyl methanesulfonate decreases expression ISO RGD:619568 6480464 Ethyl Methanesulfonate results in decreased expression of CAV1 mRNA CTD PMID:23649840 fenofibrate increases expression ISO RGD:619568 6480464 Fenofibrate results in increased expression of CAV1 mRNA CTD PMID:15314095 formaldehyde decreases expression ISO RGD:619568 6480464 Formaldehyde results in decreased expression of CAV1 mRNA CTD PMID:23649840 fulvestrant multiple interactions EXP 6480464 fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of CAV1 mRNA], fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of CAV1 protein] CTD PMID:17091190 furan increases expression EXP 6480464 furan results in increased expression of CAV1 mRNA CTD PMID:27387713 gefitinib increases expression ISO RGD:619568 6480464 gefitinib results in increased expression of CAV1 mRNA, gefitinib results in increased expression of CAV1 protein CTD PMID:19288272 genistein decreases expression ISO RGD:619568 6480464 Genistein results in decreased expression of CAV1 mRNA CTD PMID:22228119 geranylgeraniol multiple interactions ISO RGD:619568 6480464 geranylgeraniol inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA] CTD PMID:15314095 glucose multiple interactions ISO RGD:619568 6480464 EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA], Simvastatin inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA] CTD PMID:19816600 glucose decreases expression ISO RGD:619568 6480464 Glucose results in decreased expression of CAV1 mRNA, Glucose results in decreased expression of CAV1 protein CTD PMID:19816600 hexadecanoic acid decreases phosphorylation ISO RGD:619568 6480464 Palmitic Acid results in decreased phosphorylation of CAV1 protein CTD PMID:28073184 hydrogen peroxide multiple interactions ISO RGD:619568 6480464 Hydrogen Peroxide inhibits the reaction [Acetylcysteine results in increased ubiquitination of and results in increased degradation of CAV1 protein] more ... CTD PMID:12640124 more ... hydrogen peroxide increases phosphorylation ISO RGD:619568 6480464 Hydrogen Peroxide results in increased phosphorylation of CAV1 protein CTD PMID:23246481 , PMID:25512378 hydrogen peroxide increases response to substance ISO RGD:619568 6480464 CAV1 protein results in increased susceptibility to Hydrogen Peroxide CTD PMID:12640124 hydrogen peroxide increases expression ISO RGD:1553438 6480464 Hydrogen Peroxide results in increased expression of CAV1 mRNA, Hydrogen Peroxide results in increased expression of CAV1 protein CTD PMID:12134086 , PMID:17108117 hydrogen peroxide multiple interactions ISO RGD:1553438 6480464 [Hydrogen Peroxide co-treated with CAV1 protein] results in increased expression of CDKN1A protein more ... CTD PMID:12134086 more ... hydrogen peroxide increases expression ISO RGD:619568 6480464 Hydrogen Peroxide results in increased expression of CAV1 mRNA, Hydrogen Peroxide results in increased expression of CAV1 protein CTD PMID:18385095 iron atom affects localization EXP 6480464 Iron affects the localization of CAV1 protein CTD PMID:17172471 iron(0) affects localization EXP 6480464 Iron affects the localization of CAV1 protein CTD PMID:17172471 iron(2+) sulfate (anhydrous) affects localization EXP 6480464 ferrous sulfate affects the localization of CAV1 protein CTD PMID:17172471 isoprenaline multiple interactions ISO RGD:1553438 6480464 CAV1 protein promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein] CTD PMID:18820136 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of CAV1 mRNA CTD PMID:11578147 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of CAV1 mRNA CTD PMID:22641619 lipopolysaccharide multiple interactions ISO RGD:619568 6480464 CAV1 mutant form promotes the reaction [Lipopolysaccharides results in increased expression of NOX1 mRNA] more ... CTD PMID:24835767 , PMID:26357463 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CAV1 protein modified form CTD PMID:26357463 lipopolysaccharide multiple interactions EXP 6480464 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3 more ... CTD PMID:26357463 lipopolysaccharide affects expression ISO RGD:1553438 6480464 Lipopolysaccharides affects the expression of CAV1 mRNA, Lipopolysaccharides affects the expression of CAV1 protein CTD PMID:10948129 lipopolysaccharide multiple interactions ISO RGD:1553438 6480464 CAV1 gene mutant form promotes the reaction [Lipopolysaccharides results in increased expression of NOX2 mRNA], CAV1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of NOX2 mRNA] CTD PMID:24835767 lipopolysaccharide increases expression ISO RGD:619568 6480464 Lipopolysaccharides results in increased expression of CAV1 protein modified form CTD PMID:26357463 lithocholic acid multiple interactions ISO RGD:619568 6480464 Lithocholic Acid results in increased localization of [VDR protein co-treated with CAV1 protein] CTD PMID:20371703 lysophosphatidylcholine multiple interactions ISO RGD:619568 6480464 alpha-Tocopherol inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA] more ... CTD PMID:27257344 lysophosphatidylcholine increases expression ISO RGD:619568 6480464 Lysophosphatidylcholines results in increased expression of CAV1 mRNA, Lysophosphatidylcholines results in increased expression of CAV1 protein CTD PMID:27257344 manganese atom decreases expression ISO RGD:1553438 6480464 Manganese results in decreased expression of CAV1 mRNA, Manganese results in decreased expression of CAV1 protein CTD PMID:23499988 , PMID:23597857 manganese(0) decreases expression ISO RGD:1553438 6480464 Manganese results in decreased expression of CAV1 mRNA, Manganese results in decreased expression of CAV1 protein CTD PMID:23499988 , PMID:23597857 mercury dibromide increases expression ISO RGD:619568 6480464 mercuric bromide results in increased expression of CAV1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA CTD PMID:27188386 methotrexate decreases response to substance ISO RGD:619568 6480464 CAV1 mRNA results in decreased susceptibility to Methotrexate CTD PMID:18694510 methotrexate increases expression ISO RGD:619568 6480464 Methotrexate results in increased expression of CAV1 mRNA CTD PMID:21678067 methotrexate affects response to substance ISO RGD:619568 6480464 CAV1 mRNA affects the susceptibility to Methotrexate CTD PMID:22753658 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of CAV1 gene CTD PMID:23303685 methyl beta-cyclodextrin multiple interactions EXP 6480464 methyl-beta-cyclodextrin inhibits the reaction [Lipopolysaccharides results in increased expression of CAV1 protein modified form] CTD PMID:26357463 methyl beta-cyclodextrin multiple interactions ISO RGD:1553438 6480464 methyl-beta-cyclodextrin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] affects the localization of CAV1 protein] CTD PMID:20060843 methyl methanesulfonate decreases expression ISO RGD:619568 6480464 Methyl Methanesulfonate results in decreased expression of CAV1 mRNA CTD PMID:23649840 methylisothiazolinone decreases expression ISO RGD:619568 6480464 2-methyl-4-isothiazolin-3-one results in decreased expression of CAV1 protein CTD PMID:29110394 mifepristone multiple interactions ISO RGD:619568 6480464 Mifepristone inhibits the reaction [Progesterone results in increased expression of CAV1 mRNA] CTD PMID:15674352 miquelianin multiple interactions ISO RGD:619568 6480464 quercetin 3-O-glucuronide inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA] CTD PMID:27257344 monocrotaline decreases expression EXP 6480464 Monocrotaline results in decreased expression of CAV1 mRNA, Monocrotaline results in decreased expression of CAV1 protein CTD PMID:24835767 N-[3-(aminomethyl)benzyl]acetamidine multiple interactions ISO RGD:619568 6480464 N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Oxygen deficiency results in increased expression of CAV1 protein] CTD PMID:18717816 N-acetyl-L-cysteine decreases expression ISO RGD:619568 6480464 Acetylcysteine results in decreased expression of CAV1 CTD PMID:21148404 N-acetyl-L-cysteine multiple interactions ISO RGD:619568 6480464 Acetylcysteine inhibits the reaction [rosiglitazone results in increased expression of CAV1] more ... CTD PMID:18507034 , PMID:21148404 N-acetylsphingosine multiple interactions ISO RGD:619568 6480464 N-acetylsphingosine inhibits the reaction [CAV1 protein results in increased phosphorylation of AKT1 protein] CTD PMID:12640124 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1553438 6480464 [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of CAV1 mRNA CTD PMID:25566086 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:619568 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CAV1 protein CTD PMID:19706615 N-nitrosodiethylamine increases expression ISO RGD:619568 6480464 Diethylnitrosamine results in increased expression of CAV1 mRNA CTD PMID:21527772 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CAV mRNA CTD PMID:18164116 N-nitrosodiethylamine increases expression ISO RGD:1553438 6480464 Diethylnitrosamine results in increased expression of CAV1 mRNA CTD PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of CAV1 mRNA, Dimethylnitrosamine results in increased expression of CAV1 protein CTD PMID:18364076 , PMID:25380136 N-nitrosodimethylamine multiple interactions EXP 6480464 Dimethylnitrosamine promotes the reaction [CAV1 protein binds to NOS3 protein] CTD PMID:18364076 nicotinic acid multiple interactions EXP 6480464 [Niacin co-treated with Chromium] inhibits the reaction [CAV1 protein binds to NOS3 protein], [Niacin co-treated with Chromium] results in decreased expression of CAV1 protein CTD PMID:19027847 nimesulide increases expression ISO RGD:619568 6480464 nimesulide results in increased expression of CAV1 protein CTD PMID:18848576 nitric oxide multiple interactions ISO RGD:619568 6480464 [resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]] which results in increased abundance of Nitric Oxide more ... CTD PMID:18296501 , PMID:19706615 nitric oxide increases expression ISO RGD:619568 6480464 Nitric Oxide results in increased expression of CAV1 protein CTD PMID:19706615 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of CAV1 mRNA, nitrofen results in decreased expression of CAV1 protein CTD PMID:25078423 nitroprusside multiple interactions ISO RGD:619568 6480464 Nitroprusside results in decreased ubiquitination of and results in decreased degradation of CAV1 protein, Nitroprusside results in increased metabolism of and results in increased stability of CAV1 protein CTD PMID:19706615 nitroprusside increases expression ISO RGD:619568 6480464 Nitroprusside results in increased expression of CAV1 protein CTD PMID:19706615 NS-398 decreases expression ISO RGD:619568 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of CAV1 protein CTD PMID:18848576 nystatin multiple interactions ISO RGD:619568 6480464 Nystatin inhibits the reaction [Quercetin affects the localization of CAV1 protein] CTD PMID:17876056 octanoic acid multiple interactions ISO RGD:1553438 6480464 [octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein, [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein] CTD PMID:14984747 ouabain decreases expression ISO RGD:619568 6480464 Ouabain results in decreased expression of CAV1 mRNA CTD PMID:28795476 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CAV1 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of CAV1 mRNA CTD PMID:25729387 ozone decreases expression ISO RGD:1553438 6480464 Ozone results in decreased expression of CAV1 mRNA, Ozone results in decreased expression of CAV1 protein CTD PMID:12763052 , PMID:18207479 ozone multiple interactions ISO RGD:1553438 6480464 TNF protein affects the reaction [Ozone results in decreased expression of CAV1 protein] CTD PMID:18207479 p-menthan-3-ol increases expression ISO RGD:619568 6480464 Menthol results in increased expression of CAV1 mRNA CTD PMID:26760959 paclitaxel increases response to substance ISO RGD:619568 6480464 CAV1 mRNA results in increased susceptibility to Paclitaxel CTD PMID:16322897 paracetamol decreases expression ISO RGD:1553438 6480464 Acetaminophen results in decreased expression of CAV1 protein CTD PMID:20100502 paracetamol increases response to substance ISO RGD:1553438 6480464 CAV1 results in increased susceptibility to Acetaminophen CTD PMID:20100502 paracetamol decreases expression ISO RGD:619568 6480464 Acetaminophen results in decreased expression of CAV1 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol multiple interactions ISO RGD:1553438 6480464 CAV1 affects the reaction [Acetaminophen results in increased expression of BIRC5 protein] more ... CTD PMID:20100502 paraquat increases expression EXP 6480464 Paraquat results in increased expression of CAV1 mRNA, Paraquat results in increased expression of CAV1 protein CTD PMID:26813466 phenethyl isothiocyanate decreases expression ISO RGD:619568 6480464 phenethyl isothiocyanate results in decreased expression of CAV1 mRNA CTD PMID:26678675 phenobarbital affects expression ISO RGD:1553438 6480464 Phenobarbital affects the expression of CAV1 mRNA CTD PMID:23091169 phenylephrine multiple interactions ISO RGD:1553438 6480464 Sodium, Dietary affects the reaction [CAV1 protein results in increased susceptibility to Phenylephrine] CTD PMID:18178722 phenylmercury acetate increases expression ISO RGD:619568 6480464 Phenylmercuric Acetate results in increased expression of CAV1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA CTD PMID:27188386 pioglitazone affects expression ISO RGD:619568 6480464 pioglitazone affects the expression of CAV1 protein CTD PMID:17961437 pirinixic acid multiple interactions ISO RGD:1553438 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CAV1 mRNA CTD PMID:19710929 pirinixic acid multiple interactions ISO RGD:619568 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CAV1 mRNA CTD PMID:19710929 piroxicam decreases expression ISO RGD:619568 6480464 Piroxicam results in decreased expression of CAV1 mRNA CTD PMID:21858171 potassium chloride multiple interactions ISO RGD:1553438 6480464 Sodium, Dietary affects the reaction [CAV1 protein results in increased susceptibility to Potassium Chloride] CTD PMID:18178722 progesterone increases expression ISO RGD:619568 6480464 Progesterone results in increased expression of CAV1 mRNA CTD PMID:15674352 progesterone multiple interactions ISO RGD:619568 6480464 Mifepristone inhibits the reaction [Progesterone results in increased expression of CAV1 mRNA] CTD PMID:15674352 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of CAV1 protein] CTD PMID:26357463 quercetin multiple interactions ISO RGD:1553438 6480464 Quercetin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] affects the localization of CAV1 protein] more ... CTD PMID:12134086 more ... quercetin decreases expression ISO RGD:1553438 6480464 Quercetin results in decreased expression of CAV1 protein CTD PMID:12134086 quercetin multiple interactions ISO RGD:619568 6480464 Nystatin inhibits the reaction [Quercetin affects the localization of CAV1 protein] more ... CTD PMID:17876056 more ... quercetin increases expression EXP 6480464 Quercetin results in increased expression of CAV1 protein CTD PMID:16331104 raloxifene multiple interactions EXP 6480464 fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of CAV1 mRNA], fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of CAV1 protein] CTD PMID:17091190 raloxifene affects expression ISO RGD:619568 6480464 Raloxifene Hydrochloride affects the expression of CAV1 mRNA CTD PMID:14699072 raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of CAV1 mRNA, Raloxifene Hydrochloride results in increased expression of CAV1 protein CTD PMID:17091190 reactive oxygen species multiple interactions ISO RGD:1553438 6480464 Reactive Oxygen Species promotes the reaction [CAVIN1 protein binds to CAV1 protein] CTD PMID:21705337 resveratrol affects transport ISO RGD:619568 6480464 CAV1 protein affects the transport of resveratrol CTD PMID:19321006 resveratrol multiple interactions ISO RGD:619568 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CAV1 mRNA more ... CTD PMID:18296501 , PMID:19167446 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of CAV1 protein CTD PMID:18266981 resveratrol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [Streptozocin promotes the reaction [CAV1 protein binds to NOS3 protein]], Resveratrol inhibits the reaction [Streptozocin results in increased expression of CAV1 protein] CTD PMID:18266981 resveratrol increases phosphorylation ISO RGD:619568 6480464 resveratrol results in increased phosphorylation of CAV1 protein CTD PMID:18296501 resveratrol increases response to substance ISO RGD:619568 6480464 CAV1 protein results in increased susceptibility to resveratrol CTD PMID:19321006 resveratrol increases expression ISO RGD:619568 6480464 resveratrol results in increased expression of CAV1 protein CTD PMID:19321006 SB 203580 multiple interactions ISO RGD:619568 6480464 SB 203580 inhibits the reaction [Hydrogen Peroxide promotes the reaction [SP1 protein results in increased expression of CAV1 protein]], SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of CAV1 protein] CTD PMID:17108117 , PMID:25512378 SB 203580 multiple interactions ISO RGD:1553438 6480464 [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein] more ... CTD PMID:14984747 more ... SB 431542 multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:619568 6480464 Silicon Dioxide analog results in increased expression of CAV1 mRNA, Silicon Dioxide results in increased expression of CAV1 mRNA CTD PMID:25895662 , PMID:28425640 silicon dioxide decreases expression ISO RGD:1553438 6480464 Silicon Dioxide results in decreased expression of CAV1 mRNA CTD PMID:29203145 simvastatin multiple interactions ISO RGD:619568 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA] CTD PMID:19816600 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV1 protein] CTD PMID:16698853 simvastatin decreases expression ISO RGD:1553438 6480464 Simvastatin results in decreased expression of CAV1 protein CTD PMID:18224302 simvastatin multiple interactions ISO RGD:1553438 6480464 Simvastatin promotes the reaction [[APOA4 protein co-treated with CBS protein] affects the expression of CAV1 protein] CTD PMID:18224302 sodium arsenite multiple interactions ISO RGD:619568 6480464 AKT1 mutant form inhibits the reaction [CAV1 protein results in increased susceptibility to sodium arsenite], wortmannin inhibits the reaction [CAV1 protein results in increased susceptibility to sodium arsenite] CTD PMID:12640124 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of CAV1 protein CTD PMID:19072884 sodium arsenite increases expression ISO RGD:1553438 6480464 sodium arsenite results in increased expression of CAV1 protein CTD PMID:17123562 , PMID:29044176 sodium arsenite decreases expression ISO RGD:1553438 6480464 sodium arsenite results in decreased expression of CAV1 mRNA CTD PMID:16014739 sodium arsenite increases response to substance ISO RGD:619568 6480464 CAV1 protein results in increased susceptibility to sodium arsenite CTD PMID:12640124 Soman increases expression EXP 6480464 Soman results in increased expression of CAV mRNA, Soman results in increased expression of CAV1 mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 resveratrol inhibits the reaction [Streptozocin promotes the reaction [CAV1 protein binds to NOS3 protein]] more ... CTD PMID:18266981 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of CAV1 protein CTD PMID:18266981 sulfasalazine multiple interactions ISO RGD:1553438 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[Sulfasalazine results in decreased activity of SLC7A11 protein] which results in increased expression of CAV1 mRNA], [Sulfasalazine results in decreased activity of SLC7A11 protein] which results in increased expression of CAV1 mRNA CTD PMID:19015640 tamoxifen affects expression ISO RGD:619568 6480464 Tamoxifen affects the expression of CAV1 mRNA CTD PMID:14699072 tamoxifen increases expression ISO RGD:619568 6480464 Tamoxifen results in increased expression of CAV1 protein CTD PMID:19288272 taurocholic acid increases secretion ISO RGD:619568 6480464 CAV1 protein results in increased secretion of Taurocholic Acid CTD PMID:14647059 tert-butyl hydroperoxide increases expression ISO RGD:619568 6480464 tert-Butylhydroperoxide results in increased expression of CAV1 mRNA CTD PMID:15963989 testosterone multiple interactions ISO RGD:619568 6480464 [FSHB protein co-treated with Testosterone] results in decreased expression of CAV1 mRNA CTD PMID:18535249 tetrachloromethane increases expression ISO RGD:1553438 6480464 Carbon Tetrachloride results in increased expression of CAV1 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:1553438 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CAV1 mRNA CTD PMID:30517762 tetraphene multiple interactions ISO RGD:1553438 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA CTD PMID:27858113 theophylline increases expression ISO RGD:619568 6480464 Theophylline results in increased expression of CAV1 mRNA CTD PMID:16083514 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CAV1 mRNA CTD PMID:23411599 titanium dioxide decreases expression ISO RGD:1553438 6480464 titanium dioxide results in decreased expression of CAV1 mRNA CTD PMID:23557971 , PMID:27760801 titanium dioxide increases expression ISO RGD:619568 6480464 titanium dioxide results in increased expression of CAV1 protein CTD PMID:30910687 tolfenamic acid multiple interactions ISO RGD:619568 6480464 CAV1 protein affects the reaction [tolfenamic acid results in decreased expression of TGFBR2 protein] CTD PMID:31381904 toluene 2,4-diisocyanate multiple interactions ISO RGD:619568 6480464 AG 1879 inhibits the reaction [Toluene 2 more ... CTD PMID:29940203 , PMID:30261222 toluene 2,4-diisocyanate multiple interactions ISO RGD:1553438 6480464 FPS-ZM1 inhibits the reaction [Toluene 2, 4-Diisocyanate results in increased phosphorylation of CAV1 protein] CTD PMID:30261222 toluene 2,4-diisocyanate increases phosphorylation ISO RGD:619568 6480464 Toluene 2, 4-Diisocyanate analog results in increased phosphorylation of CAV1 protein CTD PMID:30261222 toluene 2,4-diisocyanate increases phosphorylation ISO RGD:1553438 6480464 Toluene 2, 4-Diisocyanate results in increased phosphorylation of CAV1 protein CTD PMID:30261222 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CAV1 mRNA CTD PMID:25729387 triadimefon decreases expression ISO RGD:619568 6480464 triadimefon analog results in decreased expression of CAV1 mRNA, triadimefon results in decreased expression of CAV1 mRNA CTD PMID:26238599 , PMID:26705709 trichostatin A increases expression ISO RGD:619568 6480464 trichostatin A results in increased expression of CAV1 mRNA CTD PMID:24935251 more ... trichostatin A multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA CTD PMID:27188386 triclosan increases expression ISO RGD:619568 6480464 Triclosan results in increased expression of CAV1 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO RGD:1553438 6480464 trimellitic anhydride results in decreased expression of CAV1 mRNA CTD PMID:19042947 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of CAV1 mRNA CTD PMID:21515302 tyrphostin AG 1478 multiple interactions ISO RGD:619568 6480464 RTKI cpd inhibits the reaction [Rosiglitazone results in increased expression of CAV1] CTD PMID:18507034 valproic acid decreases expression ISO RGD:619568 6480464 Valproic Acid results in decreased expression of CAV1 mRNA CTD PMID:29154799 , PMID:29501571 valproic acid increases methylation ISO RGD:619568 6480464 Valproic Acid results in increased methylation of CAV1 gene CTD PMID:29501571 valproic acid multiple interactions ISO RGD:619568 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:619568 6480464 Valproic Acid results in increased expression of CAV1 mRNA, Valproic Acid results in increased expression of CAV1 protein CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:619568 6480464 Valproic Acid results in decreased methylation of CAV1 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:619568 6480464 Valproic Acid affects the expression of CAV1 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CAV mRNA CTD PMID:19015723 vitamin E multiple interactions ISO RGD:619568 6480464 alpha-Tocopherol inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA] CTD PMID:27257344 vitamin E multiple interactions ISO RGD:1553438 6480464 Vitamin E inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein] CTD PMID:12134086 vorinostat increases expression ISO RGD:619568 6480464 vorinostat results in increased expression of CAV1 mRNA CTD PMID:26272509 wogonin multiple interactions ISO RGD:619568 6480464 wogonin inhibits the reaction [Anisomycin results in increased phosphorylation of CAV1 protein], wogonin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of CAV1 protein] CTD PMID:23246481 wortmannin multiple interactions ISO RGD:619568 6480464 wortmannin inhibits the reaction [CAV1 protein results in increased susceptibility to Hydrogen Peroxide], wortmannin inhibits the reaction [CAV1 protein results in increased susceptibility to sodium arsenite] CTD PMID:12640124
Biological Process angiogenesis ISO RGD:1553438 1624291 MGI:MGI:95516 (MGI:MGI:3629009 , PMID:12759260) RGD MGI:MGI:3629009 , PMID:12759260 angiogenesis IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 angiotensin-activated signaling pathway involved in heart process ISO RGD:1553438 1624291 UniProtKB:P09470 (MGI:MGI:5607357 , PMID:25017399) RGD MGI:MGI:5607357 , PMID:25017399 angiotensin-activated signaling pathway involved in heart process IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 animal organ regeneration IEP 6784521 RGD apoptotic signaling pathway ISO RGD:619568 1624291 (PMID:21382479) RGD PMID:21382479 apoptotic signaling pathway IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 basement membrane organization ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:2176684 , PMID:11884617) RGD MGI:MGI:2176684 , PMID:11884617 basement membrane organization IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 calcium ion homeostasis ISO RGD:1553438 1624291 MGI:MGI:2654177 (MGI:MGI:2653403 , PMID:12651616) RGD MGI:MGI:2653403 , PMID:12651616 calcium ion transport ISO RGD:1553438 1624291 MGI:MGI:2154537 (MGI:MGI:3715046 , PMID:17416589) RGD MGI:MGI:3715046 , PMID:17416589 calcium ion transport IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 caveola assembly ISO RGD:12250353 1624291 (PMID:12743374) RGD PMID:12743374 caveola assembly IBA MGI:MGI:102709 more ... 13792537 PMID:21873635 GO_Central caveola assembly ISO RGD:1553438 1624291 MGI:MGI:2180372 more ... RGD MGI:MGI:2176684 more ... caveola assembly IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 caveola assembly IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 caveola assembly ISO RGD:619568 1624291 UniProtKB:P49817 (PMID:12633858), (PMID:25006397) RGD PMID:12633858 , PMID:25006397 caveolin-mediated endocytosis ISO RGD:619568 1624291 (PMID:19931615) RGD PMID:19931615 caveolin-mediated endocytosis IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell differentiation IBA MGI:MGI:102709 more ... 13792537 PMID:21873635 GO_Central cellular calcium ion homeostasis IMP 2289122 RGD cellular calcium ion homeostasis IBA MGI:MGI:102709 more ... 13792537 PMID:21873635 GO_Central cellular calcium ion homeostasis ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3707284 , PMID:17098833) RGD MGI:MGI:3707284 , PMID:17098833 cellular response to exogenous dsRNA ISO RGD:619568 1624291 (PMID:25204797) RGD PMID:25204797 cellular response to exogenous dsRNA IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 cellular response to hyperoxia ISO RGD:619568 1624291 (PMID:21382479) RGD PMID:21382479 cellular response to hyperoxia IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 cellular response to mechanical stimulus IDA 6849300 RGD cellular response to peptide hormone stimulus ISO RGD:1553438 1624291 UniProtKB:P09470 (MGI:MGI:5607357 , PMID:25017399) RGD MGI:MGI:5607357 , PMID:25017399 cellular response to starvation ISO RGD:619568 1624291 (PMID:15657086) RGD PMID:15657086 cellular response to transforming growth factor beta stimulus ISO RGD:1553438 1624291 (MGI:MGI:5289760, PMID:21829547) RGD MGI:MGI:5289760 , PMID:21829547 cellular response to transforming growth factor beta stimulus IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 cellular senescence IMP 9588563 RGD cholesterol efflux IMP 2289119 RGD cholesterol homeostasis ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3693431 , PMID:16603689) RGD MGI:MGI:3693431 , PMID:16603689 cholesterol homeostasis IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 inactivation of MAPK activity ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:2450774 , PMID:12388077) RGD MGI:MGI:2450774 , PMID:12388077 inactivation of MAPK activity IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 insulin receptor internalization IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 insulin receptor internalization ISO RGD:1553438 1624291 (MGI:MGI:6378123, PMID:27110488) RGD MGI:MGI:6378123 , PMID:27110488 lactation ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3703676 , PMID:12388746) RGD MGI:MGI:3703676 , PMID:12388746 lactation IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 lipid storage ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:2176684 , PMID:11884617) RGD MGI:MGI:2176684 , PMID:11884617 lipid storage IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 lipid transport IBA PANTHER:PTN000851526 , WB:WBGene00000302 13792537 PMID:21873635 GO_Central maintenance of protein location in cell IMP 8553801 PMID:18162583 BHF-UCL mammary gland development ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3703676 , PMID:12388746) RGD MGI:MGI:3703676 , PMID:12388746 mammary gland involution ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3703676 , PMID:12388746) RGD MGI:MGI:3703676 , PMID:12388746 mammary gland involution IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 membrane depolarization ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3707284 , PMID:17098833) RGD MGI:MGI:3707284 , PMID:17098833 membrane depolarization IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 microtubule polymerization IMP 1582162 RGD negative regulation of anoikis ISO RGD:619568 1624291 (PMID:22277751) RGD PMID:22277751 negative regulation of anoikis IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of anoikis IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of anoikis ISO RGD:1553438 1624291 (MGI:MGI:5437406, PMID:22277751) RGD MGI:MGI:5437406 , PMID:22277751 negative regulation of BMP signaling pathway ISO RGD:619568 1624291 (PMID:15657086) RGD PMID:15657086 negative regulation of canonical Wnt signaling pathway ISO RGD:1553438 1624291 (MGI:MGI:4821088, PMID:10816572) RGD MGI:MGI:4821088 , PMID:10816572 negative regulation of canonical Wnt signaling pathway ISS UniProtKB:P49817 1600115 GO_REF:0000024 UniProt GO_REF:0000024 negative regulation of canonical Wnt signaling pathway IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of cation channel activity IDA 6849299 RGD negative regulation of cell population proliferation ISO RGD:1553438 1624291 MGI:MGI:2154537 more ... RGD MGI:MGI:2450774 more ... negative regulation of cytokine-mediated signaling pathway ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3703676 , PMID:12388746) RGD MGI:MGI:3703676 , PMID:12388746 negative regulation of cytokine-mediated signaling pathway IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of endothelial cell proliferation IMP 1582167 RGD negative regulation of endothelial cell proliferation IBA MGI:MGI:102709 more ... 13792537 PMID:21873635 GO_Central negative regulation of endothelial cell proliferation IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of endothelial cell proliferation ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:2176684 , PMID:11884617) RGD MGI:MGI:2176684 , PMID:11884617 negative regulation of epithelial cell differentiation ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3703676 , PMID:12388746) RGD MGI:MGI:3703676 , PMID:12388746 negative regulation of epithelial cell differentiation IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of ERK1 and ERK2 cascade IDA 6849300 RGD negative regulation of inward rectifier potassium channel activity IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of inward rectifier potassium channel activity ISO RGD:619568 1624291 (PMID:18923542) RGD PMID:18923542 negative regulation of MAP kinase activity ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3703676 , PMID:12388746) RGD MGI:MGI:3703676 , PMID:12388746 negative regulation of MAPK cascade ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3703676 , PMID:12388746) RGD MGI:MGI:3703676 , PMID:12388746 negative regulation of muscle cell apoptotic process IMP 2289114 RGD negative regulation of necroptotic process ISO RGD:1553438 1624291 (MGI:MGI:5464050, PMID:23049990) RGD MGI:MGI:5464050 , PMID:23049990 negative regulation of necroptotic process IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of neuron differentiation IMP 6784523 ; 8662269 RGD negative regulation of nitric oxide biosynthetic process ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:2450774 , PMID:12388077) RGD MGI:MGI:2450774 , PMID:12388077 negative regulation of nitric oxide biosynthetic process IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of nitric-oxide synthase activity ISO RGD:1553438 1624291 MGI:MGI:2154537 (MGI:MGI:3612726 more ... RGD MGI:MGI:3612726 more ... negative regulation of nitric-oxide synthase activity IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of peptidyl-serine phosphorylation ISO RGD:619568 1624291 (PMID:18081315) RGD PMID:18081315 negative regulation of peptidyl-serine phosphorylation IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of peptidyl-tyrosine autophosphorylation ISO RGD:619568 1624291 (PMID:25006397) RGD PMID:25006397 negative regulation of peptidyl-tyrosine autophosphorylation IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of peptidyl-tyrosine autophosphorylation IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of peptidyl-tyrosine autophosphorylation ISO RGD:1553438 1624291 (MGI:MGI:5607357, PMID:25017399) RGD MGI:MGI:5607357 , PMID:25017399 negative regulation of pinocytosis ISO RGD:619568 1624291 (PMID:23583380) RGD PMID:23583380 negative regulation of pinocytosis IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of potassium ion transmembrane transport ISO RGD:619568 1624291 (PMID:18923542) RGD PMID:18923542 negative regulation of protein binding ISO RGD:619568 1624291 (PMID:16890161) RGD PMID:16890161 negative regulation of protein binding IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of protein tyrosine kinase activity ISO RGD:619568 1624291 (PMID:25006397) RGD PMID:25006397 negative regulation of protein tyrosine kinase activity IBA MGI:MGI:102709 more ... 13792537 PMID:21873635 GO_Central negative regulation of protein tyrosine kinase activity IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of protein tyrosine kinase activity IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of protein tyrosine kinase activity ISO RGD:1553438 1624291 (MGI:MGI:5607357, PMID:25017399) RGD MGI:MGI:5607357 , PMID:25017399 negative regulation of protein ubiquitination ISO RGD:619568 1624291 (PMID:22277751) RGD PMID:22277751 negative regulation of protein ubiquitination IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of protein ubiquitination IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of protein ubiquitination ISO RGD:1553438 1624291 (MGI:MGI:5437406, PMID:22277751) RGD MGI:MGI:5437406 , PMID:22277751 negative regulation of receptor signaling pathway via JAK-STAT ISO RGD:1553438 1624291 MGI:MGI:2180364 more ... RGD MGI:MGI:3703676 , PMID:12388746 negative regulation of signal transduction ISO RGD:1553438 1624291 (MGI:MGI:1329872, PMID:9685399) RGD MGI:MGI:1329872 , PMID:9685399 negative regulation of smooth muscle cell proliferation IMP 6849298 RGD negative regulation of transcription by RNA polymerase II ISO RGD:1553438 1624291 (MGI:MGI:4821088, PMID:10816572) RGD MGI:MGI:4821088 , PMID:10816572 negative regulation of transcription by RNA polymerase II ISS UniProtKB:P49817 1600115 GO_REF:0000024 UniProt GO_REF:0000024 negative regulation of transcription by RNA polymerase II IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of transforming growth factor beta receptor signaling pathway ISO RGD:619568 1624291 (PMID:25893292) RGD PMID:25893292 negative regulation of transforming growth factor beta receptor signaling pathway ISS UniProtKB:Q03135 1600115 GO_REF:0000024 UniProt GO_REF:0000024 negative regulation of transforming growth factor beta receptor signaling pathway IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of tyrosine phosphorylation of STAT protein IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of tyrosine phosphorylation of STAT protein ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3703676 , PMID:12388746) RGD MGI:MGI:3703676 , PMID:12388746 nitric oxide homeostasis ISO RGD:1553438 1624291 MGI:MGI:2386787 (MGI:MGI:2385522 , PMID:12177436) RGD MGI:MGI:2385522 , PMID:12177436 nitric oxide homeostasis IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of calcium ion transport into cytosol ISO RGD:1553438 1624291 (MGI:MGI:3837270, PMID:19052258) RGD MGI:MGI:3837270 , PMID:19052258 positive regulation of calcium ion transport into cytosol IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of canonical Wnt signaling pathway ISO RGD:619568 1624291 (PMID:16890161) RGD PMID:16890161 positive regulation of canonical Wnt signaling pathway IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of catalytic activity ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3708038 , PMID:17349656) RGD MGI:MGI:3708038 , PMID:17349656 positive regulation of cell adhesion molecule production ISO RGD:619568 1624291 (PMID:25204797) RGD PMID:25204797 positive regulation of cell adhesion molecule production IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of cell migration IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of cell migration ISO RGD:619568 1624291 (PMID:21109942) RGD PMID:21109942 positive regulation of cholesterol efflux ISO RGD:619568 1624291 (PMID:24576892) RGD PMID:24576892 positive regulation of cholesterol efflux IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of cold-induced thermogenesis ISS UniProtKB:P49817 13673783 PMID:15734843 YuBioLab positive regulation of cold-induced thermogenesis ISO RGD:1553438 1624291 (MGI:MGI:3614211, PMID:15734843) RGD MGI:MGI:3614211 , PMID:15734843 positive regulation of endocytosis IMP 2289117 RGD positive regulation of endothelial cell proliferation IMP 6849298 RGD positive regulation of ER-associated ubiquitin-dependent protein catabolic process ISO RGD:619568 1624291 (PMID:24089527) RGD PMID:24089527 positive regulation of ER-associated ubiquitin-dependent protein catabolic process IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of extrinsic apoptotic signaling pathway ISO RGD:619568 1624291 (PMID:21382479) RGD PMID:21382479 positive regulation of extrinsic apoptotic signaling pathway IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of gap junction assembly ISO RGD:1553438 1624291 (MGI:MGI:5607357, PMID:25017399) RGD MGI:MGI:5607357 , PMID:25017399 positive regulation of gap junction assembly IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of gene expression ISO RGD:1553438 1624291 (MGI:MGI:5607357, PMID:25017399) RGD MGI:MGI:5607357 , PMID:25017399 positive regulation of gene expression IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of intrinsic apoptotic signaling pathway ISO RGD:619568 1624291 (PMID:21382479) RGD PMID:21382479 positive regulation of intrinsic apoptotic signaling pathway IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of microtubule polymerization IMP 1582162 RGD positive regulation of NF-kappaB transcription factor activity IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of NF-kappaB transcription factor activity ISO RGD:619568 1624291 (PMID:23319823) RGD PMID:23319823 positive regulation of peptidase activity IEA GO:0016504 1600115 GO_REF:0000108 GOC GO_REF:0000108 positive regulation of peptidyl-serine phosphorylation ISO RGD:619568 1624291 (PMID:18081315) RGD PMID:18081315 positive regulation of peptidyl-serine phosphorylation IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of protein binding ISO RGD:619568 1624291 (PMID:24089527) RGD PMID:24089527 positive regulation of protein binding IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of protein ubiquitination ISO RGD:619568 1624291 (PMID:24089527) RGD PMID:24089527 positive regulation of protein ubiquitination IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of signal transduction IMP 2289114 RGD positive regulation of toll-like receptor 3 signaling pathway ISO RGD:619568 1624291 (PMID:25204797) RGD PMID:25204797 positive regulation of toll-like receptor 3 signaling pathway IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of vasoconstriction IMP 6849297 RGD positive regulation of vasoconstriction IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of vasoconstriction ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:2176684 , PMID:11884617) RGD MGI:MGI:2176684 , PMID:11884617 posttranscriptional regulation of gene expression ISO RGD:1553438 1624291 (MGI:MGI:5607357, PMID:25017399) RGD MGI:MGI:5607357 , PMID:25017399 posttranscriptional regulation of gene expression IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein localization ISO RGD:1553438 1624291 MGI:MGI:2154537 (MGI:MGI:3715046 , PMID:17416589) RGD MGI:MGI:3715046 , PMID:17416589 protein localization IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein localization to basolateral plasma membrane ISO RGD:12250353 1624291 (PMID:12743374) RGD PMID:12743374 protein localization to plasma membrane raft ISO RGD:12250353 1624291 (PMID:12743374) RGD PMID:12743374 receptor internalization ISO RGD:619568 1624291 (PMID:25893292) RGD PMID:25893292 receptor internalization ISS UniProtKB:Q03135 1600115 GO_REF:0000024 UniProt GO_REF:0000024 receptor internalization involved in canonical Wnt signaling pathway ISO RGD:619568 1624291 (PMID:16890161) RGD PMID:16890161 receptor internalization involved in canonical Wnt signaling pathway IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 receptor-mediated endocytosis of virus by host cell ISO RGD:619568 1624291 UniProtKB:P51636 (PMID:21047970) RGD PMID:21047970 receptor-mediated endocytosis of virus by host cell IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of blood coagulation ISO RGD:619568 1624291 (PMID:17848177) RGD PMID:17848177 regulation of blood coagulation IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of cell communication by electrical coupling involved in cardiac conduction ISO RGD:1553438 1624291 (MGI:MGI:5607357, PMID:25017399) RGD MGI:MGI:5607357 , PMID:25017399 regulation of cell communication by electrical coupling involved in cardiac conduction IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of cytosolic calcium ion concentration ISO RGD:619568 1624291 (PMID:19052258) RGD PMID:19052258 regulation of entry of bacterium into host cell ISO RGD:619568 1624291 (PMID:24625804) RGD PMID:24625804 regulation of entry of bacterium into host cell IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of fatty acid metabolic process ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:2176684 , PMID:11884617) RGD MGI:MGI:2176684 , PMID:11884617 regulation of fatty acid metabolic process IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of heart rate by cardiac conduction ISO RGD:1553438 1624291 (MGI:MGI:5607357, PMID:25017399) RGD MGI:MGI:5607357 , PMID:25017399 regulation of heart rate by cardiac conduction IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of membrane repolarization during action potential ISO RGD:619568 1624291 (PMID:18923542) RGD PMID:18923542 regulation of membrane repolarization during action potential IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of peptidase activity ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3708038 , PMID:17349656) RGD MGI:MGI:3708038 , PMID:17349656 regulation of ruffle assembly ISO RGD:619568 1624291 (PMID:24625804) RGD PMID:24625804 regulation of ruffle assembly IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of smooth muscle contraction ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3695200 more ... RGD MGI:MGI:3695200 more ... regulation of smooth muscle contraction IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of the force of heart contraction ISO RGD:1553438 1624291 MGI:MGI:2154537 (MGI:MGI:3612726 , PMID:16380094) RGD MGI:MGI:3612726 , PMID:16380094 regulation of the force of heart contraction by chemical signal ISO RGD:1553438 1624291 MGI:MGI:97362 (MGI:MGI:3832129 , PMID:18951881) RGD MGI:MGI:3832129 , PMID:18951881 regulation of the force of heart contraction by chemical signal IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of ventricular cardiac muscle cell action potential ISO RGD:1553438 1624291 (MGI:MGI:5607357, PMID:25017399) RGD MGI:MGI:5607357 , PMID:25017399 regulation of ventricular cardiac muscle cell action potential IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to bacterium ISO RGD:619568 1624291 (PMID:24625804) RGD PMID:24625804 response to bacterium IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to calcium ion ISO RGD:1553438 1624291 (MGI:MGI:3837270, PMID:19052258) RGD MGI:MGI:3837270 , PMID:19052258 response to calcium ion IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to drug IEP 2289098 RGD response to estrogen ISO RGD:619568 1624291 (PMID:12388746) RGD PMID:12388746 response to estrogen IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to estrogen IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to estrogen ISO RGD:1553438 1624291 (MGI:MGI:3703676, PMID:12388746) RGD MGI:MGI:3703676 , PMID:12388746 response to gamma radiation IEP 2289115 RGD response to glucocorticoid IEP 2289118 RGD response to hypoxia ISO RGD:1553438 1624291 MGI:MGI:2154537 (MGI:MGI:3713614 , PMID:16601228) RGD MGI:MGI:3713614 , PMID:16601228 response to hypoxia IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to ischemia ISO RGD:1553438 1624291 MGI:MGI:2180372 (MGI:MGI:3783955 , PMID:17293479) RGD MGI:MGI:3783955 , PMID:17293479 response to ischemia IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to mechanical stimulus IMP 2289121 RGD response to nutrient IEP 2289099 RGD response to progesterone ISO RGD:619568 1624291 (PMID:12388746) RGD PMID:12388746 response to progesterone IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 skeletal muscle tissue development ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3695802 , PMID:17200204) RGD MGI:MGI:3695802 , PMID:17200204 skeletal muscle tissue development IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 T cell costimulation ISO RGD:619568 1624291 (PMID:17287217) RGD PMID:17287217 T cell costimulation ISS UniProtKB:Q03135 1600115 GO_REF:0000024 UniProt GO_REF:0000024 T cell costimulation IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 triglyceride metabolic process ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:2176684 , PMID:11884617) RGD MGI:MGI:2176684 , PMID:11884617 triglyceride metabolic process IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 vasculogenesis ISO RGD:1553438 1624291 MGI:MGI:2154537 (MGI:MGI:3713614 , PMID:16601228) RGD MGI:MGI:3713614 , PMID:16601228 vasculogenesis IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 vasoconstriction ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3707284 , PMID:17098833) RGD MGI:MGI:3707284 , PMID:17098833 vasoconstriction IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 vesicle organization ISO RGD:12250353 1624291 (PMID:12743374) RGD PMID:12743374 wound healing IMP 9588563 RGD Cellular Component acrosomal membrane ISO RGD:1553438 1624291 (MGI:MGI:2156264, PMID:11784086) RGD MGI:MGI:2156264 , PMID:11784086 acrosomal membrane IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 apical plasma membrane ISO RGD:619568 1624291 (PMID:16904002) RGD PMID:16904002 basal plasma membrane IDA 1582171 RGD basolateral plasma membrane ISO RGD:619568 1624291 (PMID:16904002) RGD PMID:16904002 caveola IDA 1582162 ; 1601538 RGD caveola ISO RGD:13875882 1624291 (PMID:15140193) RGD PMID:15140193 caveola ISS UniProtKB:Q03135 1600115 GO_REF:0000024 UniProt GO_REF:0000024 caveola ISO RGD:619568 1624291 (PMID:15219854), (PMID:15703204), (PMID:17982011), (PMID:18081315), (PMID:19525939), (PMID:24013648), (PMID:25556234) RGD PMID:15219854 more ... caveola IDA 8554773 PMID:18054955 MGI caveola IDA 2326037 PMID:19931615 UniProt caveola ISO RGD:1553438 1624291 (MGI:MGI:2176684 more ... RGD MGI:MGI:2176684 more ... caveola ISO RGD:12250353 1624291 (PMID:8385608) RGD PMID:8385608 caveolar macromolecular signaling complex ISO RGD:1553438 1624291 (MGI:MGI:2176684, PMID:11884617) RGD MGI:MGI:2176684 , PMID:11884617 caveolar macromolecular signaling complex IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell IEA GO:0006874 1600115 GO_REF:0000108 GOC GO_REF:0000108 cell IEA GO:0051480 1600115 GO_REF:0000108 GOC GO_REF:0000108 cell IEA GO:0010524 1600115 GO_REF:0000108 GOC GO_REF:0000108 cell IEA GO:0032507 1600115 GO_REF:0000108 GOC GO_REF:0000108 cell cortex ISO RGD:1553438 1624291 (MGI:MGI:1351425, PMID:10631317) RGD MGI:MGI:1351425 , PMID:10631317 cell cortex IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell surface IDA 2300101 RGD cilium ISO RGD:1553438 1624291 (MGI:MGI:2156264, PMID:11784086) RGD MGI:MGI:2156264 , PMID:11784086 cilium IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 cytoplasm IDA 2300101 RGD cytoplasmic vesicle IDA 2289119 RGD cytoplasmic vesicle IBA PANTHER:PTN000090213 more ... 13792537 PMID:21873635 GO_Central cytoplasmic vesicle ISO RGD:619568 1624291 (PMID:19931615), (PMID:22792322) RGD PMID:19931615 , PMID:22792322 cytosol IDA 1624961 RGD endoplasmic reticulum ISO RGD:1553438 1624291 (MGI:MGI:3706740, PMID:10787428) RGD MGI:MGI:3706740 , PMID:10787428 endoplasmic reticulum IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 endoplasmic reticulum IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 endoplasmic reticulum ISS UniProtKB:Q03135 1600115 GO_REF:0000024 HGNC GO_REF:0000024 endoplasmic reticulum ISO RGD:619568 1624291 (PMID:11294831) RGD PMID:11294831 endosome ISO RGD:619568 1624291 (PMID:20682791) RGD PMID:20682791 endosome ISS UniProtKB:Q03135 1600115 GO_REF:0000024 UniProt GO_REF:0000024 endosome IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 exocytic vesicle ISO RGD:12250353 1624291 (PMID:18504258) RGD PMID:18504258 focal adhesion IDA 1582182 ; 1582159 RGD focal adhesion IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 focal adhesion IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 focal adhesion colocalizes_with ISO RGD:1553438 1624291 (MGI:MGI:5613482, PMID:12091389) RGD MGI:MGI:5613482 , PMID:12091389 focal adhesion colocalizes_with ISO RGD:619568 1624291 (PMID:12091389) RGD PMID:12091389 Golgi apparatus ISO RGD:1553438 1624291 (MGI:MGI:3706740, PMID:10787428) RGD MGI:MGI:3706740 , PMID:10787428 Golgi apparatus IBA MGI:MGI:102709 more ... 13792537 PMID:21873635 GO_Central Golgi apparatus IDA 8553801 PMID:18162583 BHF-UCL Golgi membrane ISO RGD:619568 1624291 (PMID:11294831) RGD PMID:11294831 Golgi membrane IEA UniProtKB-SubCell:SL-0134 1600115 GO_REF:0000044 UniProt GO_REF:0000044 Golgi membrane ISS UniProtKB:Q03135 1600115 GO_REF:0000024 HGNC GO_REF:0000024 integral component of membrane ISO RGD:1553438 1624291 (MGI:MGI:1330789, PMID:10460238) RGD MGI:MGI:1330789 , PMID:10460238 integral component of plasma membrane ISO RGD:1553438 1624291 (MGI:MGI:78129, PMID:8552590) RGD MGI:MGI:78129 , PMID:8552590 integral component of plasma membrane IBA MGI:MGI:102709 more ... 13792537 PMID:21873635 GO_Central integral component of plasma membrane IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 lipid droplet IDA 2300102 RGD membrane ISO RGD:619568 1624291 (PMID:24625804) RGD PMID:24625804 membrane ISO RGD:1553438 1624291 (MGI:MGI:2156264 more ... RGD MGI:MGI:2156264 more ... membrane raft IDA 1625132 RGD membrane raft ISO RGD:619568 1624291 (PMID:11294831), (PMID:14559243), (PMID:17010968), (PMID:21382479), (PMID:23262137), (PMID:24576892), (PMID:25204797), (PMID:25893292) RGD PMID:11294831 more ... membrane raft IDA 8553801 PMID:18162583 BHF-UCL membrane raft ISO RGD:1553438 1624291 (MGI:MGI:1334095 more ... RGD MGI:MGI:1334095 more ... mitochondrion IDA 1624961 RGD perinuclear region of cytoplasm ISO RGD:1553438 1624291 (MGI:MGI:78129, PMID:8552590) RGD MGI:MGI:78129 , PMID:8552590 perinuclear region of cytoplasm IBA MGI:MGI:102709 more ... 13792537 PMID:21873635 GO_Central perinuclear region of cytoplasm IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 perinuclear region of cytoplasm IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 perinuclear region of cytoplasm IDA 2326037 PMID:19931615 UniProt perinuclear region of cytoplasm ISO RGD:619568 1624291 (PMID:19931615) RGD PMID:19931615 peroxisomal membrane IDA 6849301 RGD plasma membrane IDA 1582163 ; 1582159 RGD plasma membrane IDA 14697713 PMID:16306401 ARUK-UCL plasma membrane ISO RGD:13875882 1624291 (PMID:15140193) RGD PMID:15140193 plasma membrane ISO RGD:1553438 1624291 (MGI:MGI:2176684 more ... RGD MGI:MGI:2176684 more ... plasma membrane ISO RGD:619568 1624291 (PMID:23262137) RGD GO_REF:0000054, PMID:23262137 plasma membrane IDA 8553801 PMID:18162583 BHF-UCL plasma membrane IDA 8554799 PMID:16358225 UniProt protein-containing complex IDA 6784520 RGD protein-containing complex ISO RGD:619568 1624291 (PMID:21822278), (PMID:24013648) RGD PMID:21822278 , PMID:24013648 protein-containing complex ISO RGD:1553438 1624291 UniProtKB:P11881 more ... RGD MGI:MGI:3715046 more ... sarcolemma colocalizes_with IBA MGI:MGI:107570 more ... 13792537 PMID:21873635 GO_Central Molecular Function ATPase binding ISO RGD:619568 1624291 UniProtKB:P55072 (PMID:24089527) RGD PMID:24089527 ATPase binding IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 enzyme binding ISO RGD:619568 1624291 UniProtKB:Q16647 (PMID:20122998) RGD PMID:20122998 identical protein binding ISO RGD:619568 1624291 UniProtKB:Q03135 (PMID:25006397) RGD PMID:25006397 identical protein binding IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 identical protein binding ISO RGD:1553438 1624291 UniProtKB:P49817 (MGI:MGI:78129 , PMID:8552590) RGD MGI:MGI:78129 , PMID:8552590 identical protein binding IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 inward rectifier potassium channel inhibitor activity ISO RGD:619568 1624291 (PMID:18923542) RGD PMID:18923542 inward rectifier potassium channel inhibitor activity IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 ion channel binding ISO RGD:619568 1624291 UniProtKB:Q12809 (PMID:18923542) RGD PMID:18923542 ion channel binding IBA PANTHER:PTN000090213 more ... 13792537 PMID:21873635 GO_Central ion channel binding IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 ion channel binding IPI UniProtKB:O08962 10047293 PMID:18923542 BHF-UCL kinase binding IPI RGD:2796 1601538 RGD molecular adaptor activity ISO RGD:1553438 1624291 (MGI:MGI:5607357, PMID:25017399) RGD MGI:MGI:5607357 , PMID:25017399 molecular adaptor activity IBA MGI:MGI:102709 more ... 13792537 PMID:21873635 GO_Central nitric-oxide synthase binding IPI RGD:3186 1600213 RGD nitric-oxide synthase binding IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 nitric-oxide synthase binding IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 nitric-oxide synthase binding ISO RGD:1553438 1624291 UniProtKB:P70313 (MGI:MGI:5607357 , PMID:25017399) RGD MGI:MGI:5607357 , PMID:25017399 nitric-oxide synthase binding ISO RGD:619568 1624291 UniProtKB:P29474 (PMID:12852865) RGD PMID:12852865 peptidase activator activity ISO RGD:1553438 1624291 MGI:MGI:2180364 (MGI:MGI:3708038 , PMID:17349656) RGD MGI:MGI:3708038 , PMID:17349656 peptidase activator activity IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein binding IPI UniProtKB:P35952 1298981 RGD protein binding IPI UniProtKB:P98158 14697713 PMID:16306401 ARUK-UCL protein binding ISO RGD:1553438 1624291 UniProtKB:P15208 more ... RGD MGI:MGI:2386192 more ... protein binding IPI UniProtKB:O70594 10047375 PMID:24349196 IntAct protein binding IPI UniProtKB:P41350-2 8554261 PMID:15293782 IntAct protein binding IPI UniProtKB:P41350-1 8554261 PMID:15293782 IntAct protein binding ISO RGD:619568 1624291 UniProtKB:O00194 more ... RGD PMID:10212252 more ... protein binding IPI UniProtKB:Q2IBC5 8553801 PMID:18162583 BHF-UCL protein binding IPI UniProtKB:P08050 8553801 PMID:18162583 BHF-UCL protein binding IPI UniProtKB:Q9QXA6 8554799 PMID:16358225 UniProt protein binding ISO RGD:12250353 1624291 UniProtKB:P35222 (PMID:17785436) RGD PMID:17785436 protein binding IPI RGD:2953 1582161 RGD protein binding IPI RGD:2960 1581678 RGD protein binding IPI RGD:2141 1582165 RGD protein binding IPI RGD:2062 1582266 RGD protein binding IPI RGD:3717 1582170 RGD protein binding IPI RGD:3673 2306293 RGD protein binding IPI RGD:2998 1298981 RGD protein heterodimerization activity ISO RGD:1553438 1624291 UniProtKB:Q9WVC3 (MGI:MGI:5613486 , PMID:9361015) RGD MGI:MGI:5613486 , PMID:9361015 protein heterodimerization activity IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein kinase binding ISO RGD:619568 1624291 UniProtKB:P12931 (PMID:25006397) RGD PMID:25006397 protein kinase binding IBA MGI:MGI:102709 more ... 13792537 PMID:21873635 GO_Central protein kinase binding IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein kinase binding IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein kinase binding ISO RGD:1553438 1624291 UniProtKB:P05480 (MGI:MGI:5607357 , PMID:25017399) RGD MGI:MGI:5607357 , PMID:25017399 protein-containing complex binding ISO RGD:619568 1624291 UniProtKB:P55072 (PMID:24089527) RGD PMID:24089527 protein-containing complex binding IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein-macromolecule adaptor activity ISO RGD:1553438 1624291 (MGI:MGI:5607357, PMID:25017399) RGD MGI:MGI:5607357 , PMID:25017399 protein-macromolecule adaptor activity IEA UniProtKB:P49817 , ensembl:ENSMUSP000000077991600115 GO_REF:0000107 Ensembl GO_REF:0000107 Rac GTPase binding ISO RGD:619568 1624291 UniProtKB:P63000 (PMID:24625804) RGD PMID:24625804 Rac GTPase binding IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 receptor serine/threonine kinase binding IPI RGD:2062 13513989 RGD signaling receptor binding ISO RGD:619568 1624291 UniProtKB:O75581 (PMID:16890161) RGD PMID:16890161 signaling receptor binding IEA UniProtKB:Q03135 , ensembl:ENSP000003391911600115 GO_REF:0000107 Ensembl GO_REF:0000107 SNARE binding IMP 632372 RGD syntaxin binding IMP 632372 RGD
Gene-Chemical Interaction Annotations
